PCSC
Perceptive Capital Solutions Corp
Key Financials
Shareholders' Equity
$-4796674.00
↓ 126.7%
Total Assets
$92.8M
↑ 3.2%
Operating Cash Flow
$-864653.00
↓ 144.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 424B4 | 6/17/2026 | View on SEC |
| S-4/A | 6/11/2026 | View on SEC |
| S-4/A | 6/11/2026 | View on SEC |
| 425 | 6/10/2026 | View on SEC |
| 8-K | 6/10/2026 | View on SEC |
| S-4/A | 6/1/2026 | View on SEC |
| 425 | 5/19/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| DEF 14A | 5/14/2026 | View on SEC |
| SCHEDULE 13G/A | 5/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PCSC |
| Company Name | Perceptive Capital Solutions Corp |
| CIK | 2017526 |
| Sector | Services-Medical Laboratories |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | E9 |
| Phone | 212-284-2300 |